Lino Camponovo
Nessuna posizione attualmente
Profilo
Dr. Lino Camponovo is Chief Executive Officer at Malcisbo AG.
Dr. Camponovo was previously employed as Chairman & Chief Executive Officer by Intervet India Pvt Ltd.
and Chairman & Chief Executive Officer by Veterinaria AG.
He received his doctorate degree from the University of Zurich.
Precedenti posizioni note di Lino Camponovo
| Società | Posizione | Fine |
|---|---|---|
| Intervet India Pvt Ltd. | Presidente | - |
MSD Animal Health GmbH
 MSD Animal Health GmbH Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., MSD Animal Health GmbH discovers, develops and markets human and animal health products. The company is based in Lucerne, Switzerland. | Presidente | - |
Malcisbo AG
 Malcisbo AG Pharmaceuticals: MajorHealth Technology Malcisbo AG engages in the development of novel carbohydrate-based vaccines for human and animal health. It specializes in glycoengineering technologies to create novel and efficient glycoconjugate vaccines for unmet needs in human and veterinary medicine targeting large markets. Its vaccines target the medical areas of human Campylobacter infections and and porcine Actinobacillus pleuropneumoniae infections. The company was founded by Bruno Oesch, Irene Schiller, Markus Aebi and Lino Camponovo in May 2010 and is headquartered in Schlieren, Switzerland. | Amministratore Delegato | - |
Formazione di Lino Camponovo
| University of Zurich | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 3 |
|---|---|
| Intervet India Pvt Ltd. | |
Malcisbo AG
Malcisbo AG Pharmaceuticals: MajorHealth Technology Malcisbo AG engages in the development of novel carbohydrate-based vaccines for human and animal health. It specializes in glycoengineering technologies to create novel and efficient glycoconjugate vaccines for unmet needs in human and veterinary medicine targeting large markets. Its vaccines target the medical areas of human Campylobacter infections and and porcine Actinobacillus pleuropneumoniae infections. The company was founded by Bruno Oesch, Irene Schiller, Markus Aebi and Lino Camponovo in May 2010 and is headquartered in Schlieren, Switzerland. | Health Technology |
MSD Animal Health GmbH
MSD Animal Health GmbH Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., MSD Animal Health GmbH discovers, develops and markets human and animal health products. The company is based in Lucerne, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Lino Camponovo
